Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
- Resource Type
- article
- Source
- Journal of Immunotherapy and Precision Oncology, Pp 10-12 (2022)
- Subject
selinexor carboplatin pemetrexed metastatic solid tumors selective inhibitor of nuclear export (sine) Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Immunologic diseases. Allergy RC581-607 - Language
- English
- ISSN
- 2666-2345
2590-017X